Najmeh Akhavan, MD
Internal Medicine · Dededo, GUNPI 1386805356
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $510 of the $590 with a category attached, or 86.4%. It is spread thinly across 20 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Among internal medicine clinicians in GU with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 28 payments — averaging $21.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$117
- Novartis$104
- Bayer$40
- Dendreon Pharmaceuticals LLC$33
- AbbVie$27
- Lilly USA, LLC$23
- plus $247 from 14 others
What the payments were for
- Food & beverage$51086%
- Education$8014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 3 | $117 |
| Novartis | 5 | $104 |
| Bayer | 2 | $40 |
| Dendreon Pharmaceuticals LLC | 2 | $33 |
| AbbVie | 1 | $27 |
| Lilly USA, LLC | 1 | $23 |
| Merck | 1 | $22 |
| EMD Serono, Inc. | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Puma Biotechnology, Inc. | 1 | $20 |
| AVEO Pharmaceuticals, Inc. | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Organon | 1 | $19 |
| Rigel Pharmaceuticals, Inc. | 1 | $19 |
| AstraZeneca | 1 | $17 |
| GE HealthCare | 1 | $15 |
| GSK | 1 | $14 |
| Amgen | 1 | $13 |
| Blueprint Medicines Corporation | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
How this compares
$590 in reported general payments places this provider in the 95th percentile of 35 internal medicine providers in Guam.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisone | 16 | $30 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Dededo
- Georgey EasowDededo$243
- Weerawat TananusontDededo$0
- Ji Yeong KangDededo$0
- Daniel MogesDededo$0
- Leslie Anne ChuaDededo$0
- Pichet IampornpipopchaiDededo$0
- Edison ManalotoDededo$0
- Felix CabreraDededo$0
- Donald PrestonDededo$0
- Pei-Chang LiuDededo$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.